Review

Published on 29 Jul 2022

Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level

in Cancer Molecular Targets and Therapeutics

Francesca Maria Bosisio
Yannick Van Herck
Julie Messiaen
Maddalena Maria Bolognesi
Lukas Marcelis
Matthias Van Haele
Giorgio Cattoretti
Asier Antoranz
Frederik De Smet

Frontiers in Oncology

doi 10.3389/fonc.2022.918900

10,607 views
28 citations

Original Research

Published on 29 Jul 2022

Lnc-PKD2-2-3/miR-328/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU Chemoresistance

in Cancer Molecular Targets and Therapeutics

Lei Zhang
Donglai Ma
Fujun Li
Gongcai Qiu
Dongsheng Sun
Zhaolin Zeng

Frontiers in Oncology

doi 10.3389/fonc.2022.871281

2,768 views
4 citations

Original Research

Published on 28 Jul 2022

The expression, clinical relevance, and prognostic significance of HJURP in cholangiocarcinoma

in Cancer Molecular Targets and Therapeutics

Yang Yang
Jinyan Yuan
Zhenzhong Liu
Wenwen Cao
Pei Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.972550

2,115 views
4 citations

Original Research

Published on 28 Jul 2022

A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma

in Cancer Molecular Targets and Therapeutics

Fenghao Geng
Fen Yang
Fang Liu
Jianhui Zhao
Rui Zhang
Shijie Hu
Jie Zhang
Xiao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.870034

1,832 views
1 citation

Case Report

Published on 28 Jul 2022

Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma

in Cancer Molecular Targets and Therapeutics

Shu-Na Chen
Zhongyong Wang
Di-Sheng Zhou
Xue-Qi Liu
Tao-Yi Mai
Zhao-Xia Dong
Miao Li
Xing-Ding Zhang
Lin Qi

Frontiers in Oncology

doi 10.3389/fonc.2022.969191

1,284 views

Review

Published on 27 Jul 2022

Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers

in Cancer Molecular Targets and Therapeutics

Hayle Scanlan
Zachary Coffman
Jeffrey Bettencourt
Timothy Shipley
Debra E. Bramblett

Frontiers in Oncology

doi 10.3389/fonc.2022.940019

5,895 views
16 citations

Case Report

Published on 26 Jul 2022

Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1-MET fusion

in Cancer Molecular Targets and Therapeutics

Lanzi Ou
Yicong Tang
Yanming Deng
Lijie Guo
Qingqing He
Tingting He
Weineng Feng

Frontiers in Oncology

doi 10.3389/fonc.2022.911362

2,490 views
8 citations

Original Research

Published on 26 Jul 2022

Double-dose icotinib may induce the emergence of the EGFR exon 20 T790M mutation in non-small cell lung cancer patients harboring EGFR-sensitive mutation

in Cancer Molecular Targets and Therapeutics

Jianxin Chen
Xilin Wu
Junhui Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.898586

1,532 views
2 citations

Review

Published on 26 Jul 2022

Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy

in Cancer Molecular Targets and Therapeutics

Xiaolong Tang
Chumei Qi
Honghong Zhou
Yongshuo Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.972906

8,921 views
13 citations

Original Research

Published on 22 Jul 2022

Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell Phenotype

in Cancer Molecular Targets and Therapeutics

Francesca Lombardi
Francesca Rosaria Augello
Serena Artone
Emira Ayroldi
Ilaria Giusti
Vincenza Dolo
Maria Grazia Cifone
Benedetta Cinque
Paola Palumbo

Frontiers in Oncology

doi 10.3389/fonc.2022.933746

2,148 views
8 citations

Review

Published on 22 Jul 2022

Application of artificial intelligence to pancreatic adenocarcinoma

in Cancer Molecular Targets and Therapeutics

Xi Chen
Ruibiao Fu
Qian Shao
Yan Chen
Qinghuang Ye
Sheng Li
Xiongxiong He
Jinhui Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.960056

3,966 views
8 citations

Review

Published on 22 Jul 2022

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma

in Cancer Molecular Targets and Therapeutics

Wenjie Zhang
Wenlong Wu
Qiang Meng
Long Yang
Juzheng Yuan
Zelin Tian
Rui Ding
Xuan Zhang
Jianlin Wang
Kaishan Tao

Frontiers in Oncology

doi 10.3389/fonc.2022.907399

3,180 views
7 citations

Case Report

Published on 19 Jul 2022

Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature

in Cancer Molecular Targets and Therapeutics

Vincenzo Nasca
Anna Maria Frezza
Carlo Morosi
Ciriaco Buonomenna
Antonina Parafioriti
Giorgio Zappalà
Federica Bini
Paolo Giovanni Casali
Mattia Loppini
Silvia Stacchiotti

Frontiers in Oncology

doi 10.3389/fonc.2022.953149

2,164 views
2 citations

Review

Published on 19 Jul 2022

Progressing Towards a Human-Centric Approach in Cancer Research

in Cancer Molecular Targets and Therapeutics

Aditya Parekh
Subhayan Das
Chandan K. Das
Mahitosh Mandal

Frontiers in Oncology

doi 10.3389/fonc.2022.896633

2,422 views
1 citation

Review

Published on 18 Jul 2022

Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances

in Cancer Molecular Targets and Therapeutics

Hao Qin
Baowen Yuan
Wei Huang
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.924696

4,693 views
5 citations

Original Research

Published on 18 Jul 2022

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma

in Cancer Molecular Targets and Therapeutics

Qi Sun
Huxia Wang
Baoan Xiao
Dong Xue
Guanghui Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.954366

2,832 views
6 citations

Navigation group

Articles

Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level

Lnc-PKD2-2-3/miR-328/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU Chemoresistance

The expression, clinical relevance, and prognostic significance of HJURP in cholangiocarcinoma

A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma

Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma

Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers

Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1-MET fusion

Double-dose icotinib may induce the emergence of the EGFR exon 20 T790M mutation in non-small cell lung cancer patients harboring EGFR-sensitive mutation

Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy

Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell Phenotype

Application of artificial intelligence to pancreatic adenocarcinoma

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma

Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature

Progressing Towards a Human-Centric Approach in Cancer Research

Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma